Clinical trials
Phase 1/2 COVID-19 trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 7 |
| 2021 | 5 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Unknown status | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 3 |
| Artgen Biotech | 1 |
| Biocad | 1 |
| Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products | 1 |
| Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" | 1 |
| National Medical Research Radiological Centre of the Ministry of Health of Russia | 1 |
| R-Pharm | 1 |
| St. Petersburg Research Institute of Vaccines and Sera | 1 |
| State-Financed Health Facility "Samara Regional Medical Center Dinasty" | 1 |
| Tatyana Zubkova | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 13 |
| Coronavirus Infections | 5 |
| Pneumonia, Viral | 2 |
| Hypoxia | 1 |
| Respiratory Tract Infections | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.